The news of Eric Dane’s death at fifty-three from motor neurone disease is profoundly sad. Motor neurone disease, also known internationally as ALS, is a devastating condition that gradually affects the nerves responsible for movement. Over time, muscles weaken, speech can become more difficult, swallowing may be compromised and eventually breathing can be affected. It is progressive and, at present, there is no cure. That reality needs to remain steady in the background of any wider discussion.

When someone visible dies from motor neurone disease, it brings renewed attention to a condition many families have already been living with quietly. The experience is rarely dramatic in the way headlines suggest. It is slow, cumulative and deeply personal. It affects independence, identity and the most ordinary movements most of us never consciously think about.

From a biological perspective, motor neurone disease affects the long nerve cells that run from the brain and spinal cord to the muscles. These cells are metabolically demanding. They require consistent energy and protection from damage in order to function. One of the recurring themes in research into motor neurone disease and other neurodegenerative conditions is oxidative stress. In simple terms, oxidative stress refers to an imbalance between the production of reactive oxygen species, which are natural by-products of energy production, and the body’s ability to neutralise them. When reactive oxygen species accumulate, they can damage cell membranes, proteins and DNA, including within nerve cells.

This is where SOD becomes relevant. Superoxide dismutase is one of the body’s key antioxidant enzymes. Its role is to convert superoxide, a particularly reactive oxygen molecule, into a less harmful substance that can then be processed safely. In rare inherited forms of motor neurone disease, mutations in the SOD1 gene are directly involved in the disease process. That represents a small proportion of cases. However, oxidative stress more broadly appears to be part of the landscape in many neurodegenerative conditions. In my own work, looking at SOD variants offers insight into how effectively someone may handle oxidative load. It is not because their genes are defective. It is about understanding how actively certain pathways are functioning and where additional support may reduce strain.

What matters clinically is that oxidative stress is not simply about taking antioxidant supplements. It is about cumulative load and the systems that regulate it. Blood sugar instability increases oxidative stress because fluctuating glucose levels increase mitochondrial production of reactive oxygen species. Chronic stress alters inflammatory chemistry and increases oxidative burden. Poor sleep reduces the brain’s ability to clear metabolic waste and influences redox balance. Environmental exposures, including heavy metals and other toxins, add further strain. If detoxification pathways are sluggish, reactive intermediates and other by-products accumulate more readily.

This is where methylation and detoxification become relevant. Methylation is a biochemical process involved in DNA repair, neurotransmitter balance, detoxification and gene regulation. If methylation pathways are under strain, the body may struggle to process toxins efficiently, repair oxidative damage or regulate inflammatory signalling appropriately. In functional medicine, assessing methylation capacity allows us to understand how well someone may be equipped to manage cumulative stress at a cellular level. Genes are not fixed destinies. They are active instructions, and their expression is influenced by environment, nutrition, stress and time.

Detoxification pathways intersect directly with oxidative balance. The processing of environmental toxins generates reactive intermediates, and these need to be neutralised and cleared. If antioxidant systems such as SOD are already working hard, and methylation capacity is reduced, the body may have less buffer against ongoing exposure. Supporting detoxification in a careful and measured way is not about aggressive protocols. It is about ensuring nutrients, hydration, bowel function and liver pathways are functioning adequately so that load is not unnecessarily amplified.

The microbiome also sits within this network. The gut and nervous system communicate continuously through immune and metabolic pathways. Certain gut bacteria influence the production of short-chain fatty acids, including butyrate, which has regulatory effects on inflammation and gut lining integrity. When gut barrier function is compromised, inflammatory signalling increases, and that signalling can influence the nervous system. Supporting microbiome diversity and gut health therefore becomes part of reducing inflammatory load, not as a cure for motor neurone disease, but as part of supporting the broader terrain.

Motor nerves are energy-hungry cells, which brings mitochondria into the conversation. Mitochondria are responsible for producing energy inside our cells. If energy production is inefficient, cells under stress become more vulnerable to damage. Stabilising blood sugar, ensuring adequate protein, correcting micronutrient insufficiencies and supporting overall metabolic balance all influence mitochondrial efficiency. When energy production is steadier, the production of reactive oxygen species may also be moderated, linking back to the SOD pathway and oxidative balance.

The nervous system itself is not separate from this chemistry. Chronic sympathetic activation, the state of being persistently on alert, alters immune signalling, increases oxidative load and shifts inflammatory tone. Stress physiology is biochemical. Creating steadiness within the nervous system of both the person living with motor neurone disease and those caring for them is part of reducing additional physiological strain.

It is easy to swing between despair and overstatement when discussing a condition like this. Motor neurone disease is serious and requires specialist neurological care. At the same time, biology remains dynamic. Oxidative stress can be influenced. Methylation capacity can be supported. Detoxification pathways can be assessed and strengthened where appropriate. Blood sugar can be stabilised. Sleep can be improved. The microbiome can be supported. None of this reverses motor neurone disease. What it may do is reduce cumulative load on cells that are already vulnerable.

When someone like Eric Dane dies, it reminds us how intricate and delicate our biology is. The ability to move freely, to speak clearly and to breathe without effort depends on countless processes working in coordination. Supporting those processes, even in small ways, is not insignificant.

We cannot cure everything. We can, however, care carefully for the terrain in which illness unfolds. Sometimes that is the most honest and grounded contribution we can offer.